Insulet
PODD
#2037
Rank
A$13.90 B
Marketcap
A$200.38
Share price
-3.17%
Change (1 day)
-62.45%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: A$13.90 Billion

As of November 2026 Insulet has a market cap of A$13.90 Billion. This makes Insulet the world's 2037th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026A$13.90 B-54.17%
2025A$30.33 B1.46%
2024A$29.89 B34.44%
2023A$22.23 B-25.98%
2022A$30.04 B18.7%
2021A$25.31 B15.48%
2020A$21.91 B42.99%
2019A$15.32 B130%
2018A$6.66 B29.59%
2017A$5.14 B71.32%
2016A$3.00 B1.55%
2015A$2.95 B-6.71%
2014A$3.16 B38.84%
2013A$2.28 B131.12%
2012A$0.98 B13.45%
2011A$0.87 B25.52%
2010A$0.69 B15.53%
2009A$0.60 B113.98%
2008A$0.28 B-59.26%
2007A$0.68 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Insulet was reported to be:

A$14.35 Billion
by Nasdaq info icon info icon
A$14.35 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$982.77 B 6,969.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$269.45 B 1,838.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$192.83 B 1,287.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$1.808 T 12,907.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
A$1.79 B-87.09%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
A$6.52 B-53.03%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$44.40 B 219.42%๐Ÿ‡บ๐Ÿ‡ธ USA